Pharma Marketing News
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Event Calendar PReader Surveys

Share |

Accountability for Pharma Content on Social Media Sites
Who Owns and Controls the Content?

SMWGThe FDA asked for public comments regarding how pharmaceutical companies should be held accountable for a communication about its product(s) and how much control they exert over activities on the Internet, regardless of whether the promotional activity occurs on company-sponsored venues or on third-party venues. Related to this, FDA also asked whether or not pharmaceutical companies should correct misconceptions or misinformation about their products, including unapproved uses of their products that are being conveyed on a Web site outside their control, such as on a blog, social networking site, or a wiki Web site (i.e., Wikipedia).

A substantial portion of the comments submitted to the FDA by the drug industry in response to the FDA was devoted to the accountability issue and the related issue of correcting misinformation on social media sites.

Topic headings include:

  • Who Controls the Content?
  • Some Communications Are of No Concern to FDA
  • Owned, Earned, Shared Media
  • Alternative Schemas
  • Accountability
  • Conversation Is Not Advertising Says Lilly
  • Content Syndication
  • User-Generated Content
  • Patient Advocacy Special Case
  • Safe Harbor for Corrections to Misinformation

Read this article now. It's FREE...

Download PDF file

Issue: Vol. 9, No. 3: March 2010
Word Count: 2731

Also see:

Find other articles in related Topic Areas:

Vol 9, #3 Contents

Contact Information
Pharma Marketing News

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.